Mechanism of calcium phosphate stone formation in engineered 3D tubule
Mechanism of calcium phosphate stone formation in engineered 3D tubule
批准号:
9323427
负责人:
Zhihong Nie
金额:
$11.18万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-01 至 2018-12-17
关键词:
AccountingAddressAdultAffectAnimal ModelApicalAtherosclerosisBehaviorBiochemicalBiologicalBlood VesselsCalcifiedCalciumCalcium OxalateCell Culture TechniquesChemicalsChronic Kidney FailureClinicalClinical PathologyComplexCountryCrystal FormationCrystallizationCuesDepositionDevelopmentDiseaseEngineeringEpithelial CellsEpitheliumEventFiltrationGenerationsGrantGrowthIn SituIndividualInjuryIon ChannelIon TransportKidneyKidney CalculiKidney DiseasesKineticsLeadLeukocyte L1 Antigen ComplexLifeLipidsLiquid substanceMapsMicrofluidic MicrochipsMicrofluidicsMineralsMixed StoneModelingMolecularNephrolithiasisPainPermeabilityPharmacologyPhysiologicalPreventionProcessProtein SecretionRecurrenceRegulatory PathwayRenal tubule structureResearchResearch ProposalsRoleSamplingScienceSolidStructureSurfaceSystemTechniquesTestingTimeTissue EngineeringTissue ExtractsTissuesTubular formationUnited StatesWorkbasebiomineralizationcalcificationcalcium phosphatecell growth regulationcell injuryclinically relevantcostdefined contributioneconomic costfluid flowgenetic manipulationhydrodynamic flowimprovedin vivoinnovationinsightmacromoleculemineralizationnovelpreventprogramsrenal calciumsoft tissuespatiotemporaltool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Renal Calcium phosphate (CaP) and CaP plus Calcium Oxalate (CaOx) mixed crystal biomineralization results
in diseases such as nephrolithiasis, which affect over 10% of adults in the United States, accounting for over
$5 billion in economic costs in this country each year. The recurrence rate of nephrolithiasis is often high,
reaching almost 50% over a 5-year period. Despite extensive research being conducted over the past century,
the mechanism by which crystals nucleate, grow, and aggregate into stones is still poorly understood. This
program seeks to improve our understanding of the origin and mechanism of such biologically controlled
mineralization by developing a novel microfluidic-based workbench that can simulate the dynamical biological
conditions of an in vivo renal tubular system. We hypothesize that mimicking the process of in vivo CaP
deposition within this ex vivo tubular model created in microfluidics will enable us to systematically evaluate the
multifactorial mechanism of CaP crystal formation by analyzing the contribution of each dynamic
microenvironmental cue (e.g., cellular regulations, fluidic hydrodynamics and physiochemical interactions).
Further, we believe that the combination of in situ characterization techniques and in vivo-like 3D tubular
microenvironment generated in microfluidics will enable us to achieve a better understanding of the process of
CaP stone formation at molecular and cellular level. Our program is novel in its approach to examine the
mechanism of CaP stone formation in in vivo-like tubules with continuous renal fluidic flow. Unlike previous
attempts, we propose to in situ map the compositions of renal fluids and solid mineral depositions in renal
tubular structures with continuous flow of fluids, which will enable us to capture the most relevant molecular,
cellular and hydrodynamic information that are not attainable by conventional approaches. Further, our
specialized ex vivo tools can dissect the details of the complex in vivo event, revolutionizing our understanding
of stone formation at the systems level. This research program involves two objectives: i) To understand the
cellular interaction with CaP crystals under the influence of hydrodynamic renal fluid flow within 3D ex vivo
renal tubular structure engineered in microfluidics, and ii) To understand the role of physiologically and
clinically relevant molecules in the retention, dissolution, growth of CaP and/or CaOx crystals within the MF-
based ex vivo renal tubular structure. The proposed study will lead us to i) find strategies to prevent and treat
calcium stone disease in kidney; ii) gain new insights on the abnormal CaP deposition in soft tissues (namely,
extra-skeletal calcification); and iii) open up exciting research fronts in understanding the molecular and
pharmacological basis of CaP stone formation in vascular and other similar cellular microenvironments.
Because the approach is so new, we are requesting an exploratory grant to develop the enabling techniques
required for the elucidation of the general mechanism of stone formation. Our objective is to demonstrate the
feasibility of our approach from a fundamental science, engineering and biological perspective.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金